How Can We Best Measure Frailty in Cardiosurgical Patients?
cardiosurgery
frailty
outcome
risk score
Journal
Journal of clinical medicine
ISSN: 2077-0383
Titre abrégé: J Clin Med
Pays: Switzerland
ID NLM: 101606588
Informations de publication
Date de publication:
20 Apr 2023
20 Apr 2023
Historique:
received:
20
02
2023
revised:
14
03
2023
accepted:
29
03
2023
medline:
28
4
2023
pubmed:
28
4
2023
entrez:
28
4
2023
Statut:
epublish
Résumé
Frailty is gaining importance in cardiothoracic surgery and is a risk factor for adverse outcomes and mortality. Various frailty scores have since been developed, but there is no consensus which to use for cardiac surgery. In an all-comer prospective study of patients presenting for cardiac surgery, we assessed frailty and analyzed complication rates in hospital and 1-year mortality, as well as laboratory markers before and after surgery. 246 included patients were analyzed. A total of 16 patients (6.5%) were frail, and 130 patients (52.85%) were pre-frail, summarized in the frail group (FRAIL) and compared to the non-frail patients (NON-FRAIL). The mean age was 66.5 ± 9.05 years, 21.14% female. The in-hospital mortality rate was 4.88% and the 1-year mortality rate was 6.1%. FRAIL patients stayed longer in hospital (FRAIL 15.53 ± 8.5 days vs. NON-FRAIL 13.71 ± 8.94 days, frailty parameters with the highest predictive value as well as ease of use could be added to the EuroSCORE.
Sections du résumé
BACKGROUND
BACKGROUND
Frailty is gaining importance in cardiothoracic surgery and is a risk factor for adverse outcomes and mortality. Various frailty scores have since been developed, but there is no consensus which to use for cardiac surgery.
METHODS
METHODS
In an all-comer prospective study of patients presenting for cardiac surgery, we assessed frailty and analyzed complication rates in hospital and 1-year mortality, as well as laboratory markers before and after surgery.
RESULTS
RESULTS
246 included patients were analyzed. A total of 16 patients (6.5%) were frail, and 130 patients (52.85%) were pre-frail, summarized in the frail group (FRAIL) and compared to the non-frail patients (NON-FRAIL). The mean age was 66.5 ± 9.05 years, 21.14% female. The in-hospital mortality rate was 4.88% and the 1-year mortality rate was 6.1%. FRAIL patients stayed longer in hospital (FRAIL 15.53 ± 8.5 days vs. NON-FRAIL 13.71 ± 8.94 days,
CONCLUSIONS
CONCLUSIONS
frailty parameters with the highest predictive value as well as ease of use could be added to the EuroSCORE.
Identifiants
pubmed: 37109346
pii: jcm12083010
doi: 10.3390/jcm12083010
pmc: PMC10140958
pii:
doi:
Types de publication
Journal Article
Langues
eng
Subventions
Organisme : Interne Forschungsförderung Brandenburg Medical School
ID : Projekt PREDARF
Organisme : Land Brandenburg
ID : cluster cardiovascular health of the non-metropol region Brandenburg
Références
Arch Intern Med. 1996 Mar 25;156(6):645-52
pubmed: 8629876
Mech Ageing Dev. 2019 Jun;180:117-128
pubmed: 31002925
J Am Geriatr Soc. 1999 Oct;47(10):1229-37
pubmed: 10522957
Eur J Public Health. 2006 Apr;16(2):203-8
pubmed: 16076854
Chest. 2018 Jun;153(6):1378-1386
pubmed: 29559308
Can J Cardiol. 2017 Aug;33(8):1020-1026
pubmed: 28754387
J Am Coll Cardiol. 2017 Aug 8;70(6):689-700
pubmed: 28693934
Interact Cardiovasc Thorac Surg. 2011 Aug;13(2):119-23; discussion 123
pubmed: 21378017
J Gerontol A Biol Sci Med Sci. 2001 Mar;56(3):M146-56
pubmed: 11253156
Eur J Cardiothorac Surg. 2018 Jul 1;54(1):42-47
pubmed: 29408989
Crit Care Med. 2012 Jan;40(1):132-8
pubmed: 22001580
Dtsch Arztebl Int. 2020 Oct 2;117(40):668-673
pubmed: 33357351
Eur J Cardiothorac Surg. 2012 Apr;41(4):734-44; discussion 744-5
pubmed: 22378855
Ann Thorac Surg. 2009 Aug;88(2):468-74; discussion 474-5
pubmed: 19632395
CMAJ. 2014 Feb 4;186(2):E95-102
pubmed: 24277703
J Thorac Cardiovasc Surg. 2017 Dec;154(6):1990-1999
pubmed: 28734627
J Thorac Cardiovasc Surg. 2015 Mar;149(3):869-75.e1-2
pubmed: 25486976
Ann Intern Med. 2016 Nov 01;165(9):650-660
pubmed: 27548070
CMAJ. 2005 Aug 30;173(5):489-95
pubmed: 16129869
Geriatr Gerontol Int. 2016 Jan;16(1):5-20
pubmed: 26016893
Eur J Cardiothorac Surg. 2022 Aug 3;62(3):
pubmed: 35482031
Eur J Cardiothorac Surg. 2004 May;25(5):695-700
pubmed: 15082269
Lancet. 2003 Aug 23;362(9384):604-9
pubmed: 12944059
Am J Cardiol. 2015 Nov 1;116(9):1391-8
pubmed: 26342515
Work. 2012;41 Suppl 1:374-9
pubmed: 22316752
J Am Coll Cardiol. 2010 Nov 9;56(20):1668-76
pubmed: 21050978
Circ Cardiovasc Qual Outcomes. 2012 Mar 1;5(2):222-8
pubmed: 22396586
JACC Cardiovasc Interv. 2012 May;5(5):489-496
pubmed: 22625186
J Card Surg. 2020 Apr;35(4):818-825
pubmed: 32092191
J Thorac Cardiovasc Surg. 2008 Jan;135(1):180-7
pubmed: 18179938
Am J Cardiol. 2015 Jul 15;116(2):264-9
pubmed: 25963221
Thorac Cardiovasc Surg. 2019 Sep;67(6):426-427
pubmed: 30609445
J Thorac Cardiovasc Surg. 2014 Dec;148(6):3110-7
pubmed: 25199821
Ann Nutr Metab. 2008;52 Suppl 1:6-11
pubmed: 18382070
J Am Med Dir Assoc. 2007 Nov;8(9):595-603
pubmed: 17998116
Interact Cardiovasc Thorac Surg. 2014 May;18(5):580-5
pubmed: 24497604
J Clin Med. 2022 Nov 23;11(23):
pubmed: 36498482
Eur J Cardiothorac Surg. 2018 Dec 1;54(6):1102-1109
pubmed: 29897529